1. Home
  2. BLX vs PTCT Comparison

BLX vs PTCT Comparison

Compare BLX & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banco Latinoamericano de Comercio Exterior S.A.

BLX

Banco Latinoamericano de Comercio Exterior S.A.

HOLD

Current Price

$51.21

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$69.35

Market Cap

6.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLX
PTCT
Founded
1977
1998
Country
Panama
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
6.1B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
BLX
PTCT
Price
$51.21
$69.35
Analyst Decision
Buy
Analyst Count
0
18
Target Price
N/A
$76.28
AVG Volume (30 Days)
154.8K
1.0M
Earning Date
02-12-2026
02-19-2026
Dividend Yield
5.03%
N/A
EPS Growth
9.67
N/A
EPS
6.09
8.94
Revenue
$317,451,000.00
$1,779,150,000.00
Revenue This Year
$18.17
$132.16
Revenue Next Year
$6.12
N/A
P/E Ratio
$8.15
$7.91
Revenue Growth
10.24
97.54
52 Week Low
$31.14
$35.95
52 Week High
$51.00
$87.50

Technical Indicators

Market Signals
Indicator
BLX
PTCT
Relative Strength Index (RSI) 73.02 37.18
Support Level $49.33 $69.75
Resistance Level $49.78 $76.99
Average True Range (ATR) 1.09 2.60
MACD 0.14 -0.44
Stochastic Oscillator 96.44 13.85

Price Performance

Historical Comparison
BLX
PTCT

About BLX Banco Latinoamericano de Comercio Exterior S.A.

Banco Latinoamericano de Comercio Exterior SA provides financial solutions to financial institutions, companies, and investors doing business in Latin America, supporting trade and regional integration. The Bank provides foreign trade solutions to a select client base of American financial institutions and corporations and has developed a network of correspondent banking institutions with access to the international capital markets. It has two business segments: the Commercial Business Segment and the Treasury Business Segment. The majority of its revenue is generated from the Commercial Business segment.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

Share on Social Networks: